Atea Pharmaceuticals Piotroski F Score

AVIR -  USA Stock  

USD 25.03  1.02  3.92%

This module uses fundamental data of Atea Pharmaceuticals to approximate its Piotroski F score. Atea Pharmaceuticals F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Atea Pharmaceuticals. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Atea Pharmaceuticals financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please continue to Atea Pharmaceuticals Altman Z Score, Atea Pharmaceuticals Correlation, Atea Pharmaceuticals Valuation, as well as analyze Atea Pharmaceuticals Alpha and Beta and Atea Pharmaceuticals Hype Analysis.

Search Piotroski F Score 

 
Refresh
As of 07/28/2021, Long Term Debt to Equity is likely to grow to 0.007743. Also, Debt to Equity Ratio is likely to grow to 0.62. Atea Pharmaceuticals Long Term Debt to Equity is relatively stable at the moment as compared to the past year. Atea Pharmaceuticals reported last year Long Term Debt to Equity of 0.00615. As of 07/28/2021, Accounts Payable Turnover is likely to grow to 51.90, while Receivables Turnover is likely to drop 13.11.
At this time, it appears that Atea Pharmaceuticals' Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
1
Current Return On Assets
Negative
2
Change in Return on Assets
Decreased
3
Cash Flow Return on Assets
Positive
4
Current Quality of Earnings (accrual)
Improving
5
Asset Turnover Growth
Decrease
6
Current Ratio Change
Increase
7
Long Term Debt Over Assets Change
N/A
8
Change In Outstending Shares
Decrease
9
Change in Gross Margin
No Change

Atea Pharmaceuticals Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Atea Pharmaceuticals is to make sure Atea Pharmaceuticals is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Atea Pharmaceuticals' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Atea Pharmaceuticals' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares19.4 M21.6 M
Moderately Down
Increasing
Slightly volatile
Weighted Average Shares Diluted19.4 M21.6 M
Moderately Down
Increasing
Slightly volatile
Net Cash Flow from Operations320.2 M296.7 M
Significantly Up
Increasing
Slightly volatile
Total Assets931.8 M863.6 M
Significantly Up
Increasing
Slightly volatile
Total Liabilities340.8 M315.8 M
Significantly Up
Increasing
Slightly volatile
Current Assets931.6 M863.5 M
Significantly Up
Increasing
Slightly volatile
Current Liabilities340.7 M315.8 M
Significantly Up
Increasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.09840.099
Slightly Down
Decreasing
Slightly volatile

Atea Pharmaceuticals F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Atea Pharmaceuticals' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Atea Pharmaceuticals in a much-optimized way.

About Atea Pharmaceuticals Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value per Share

27.37Share
Atea Pharmaceuticals Book Value per Share is relatively stable at the moment as compared to the past year. Atea Pharmaceuticals reported last year Book Value per Share of 25.37

About Atea Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Atea Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atea Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atea Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atea Pharmaceuticals without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Pair Trading with Atea Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Atea Pharmaceuticals Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Atea Pharmaceuticals and Equillium. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Atea Pharmaceuticals Altman Z Score, Atea Pharmaceuticals Correlation, Atea Pharmaceuticals Valuation, as well as analyze Atea Pharmaceuticals Alpha and Beta and Atea Pharmaceuticals Hype Analysis. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.